The candidates were previously shown to be active in vitro against respiratory syncytial virus and human parainfluenza virus 3.

Those aged under five have seen a shocking rise in cases of several viruses in the last week, with two specific ones seeing a ...

In updates on H5N1 avian flu today, the World Health Organization (WHO) shared new details about Mexico's recent fatal case, ...

SAN JOSE, Calif., March 27, 2025--(BUSINESS WIRE)--Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company developing parainfluenza virus 5 (PIV5)-vectored vaccines that harness ...